TwinBeech Capital’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
Other funds holding MLYS
TwinBeech Capital's MLYS Position: Q3 2026 in Review
TwinBeech Capital opened a new position in Mineralys Therapeutics (MLYS) in Q3 2026: 14,000 shares worth $352K. The stake represents 0.08% of the portfolio and ranks #273 among its holdings.
219 funds tracked by Wall St. Rank hold MLYS as of Q3 2026.
- TwinBeech Capital held 14,000 shares of Mineralys Therapeutics worth $352K as of Q3 2026.
- Mineralys Therapeutics was a new TwinBeech Capital position in Q3 2026.
- Mineralys Therapeutics made up 0.08% of TwinBeech Capital's portfolio in Q3 2026, its #273 holding.
- 219 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q3 2026.
Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.